Pin to quick picksShield Thera Regulatory News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price: 105.50
Bid: 104.00
Ask: 107.00
Change: 1.50 (1.44%)
Spread: 3.00 (2.88%)
Open: 106.00
High: 106.00
Low: 103.00
Yest. Close: 104.00
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
12
Date   Source Headline
2nd Jul 201912:00 pmRNSShield Therapeutics - Additional Listing
13th Jun 20192:16 pmRNSShield Therapeutics - Result of AGM
3rd Jun 20197:00 amRNSShield Therapeutics - Update on Legal Proceedings
8th May 20197:00 amRNSShield Therapeutics - Appointment of Joint Broker
2nd May 20197:00 amRNSShield Therapeutics - Investor presentation
1st May 201911:58 amRNSShield Therapeutics - Additional Listing
30th Apr 20197:00 amRNSShield Therapeutics - 2018 Annual Report and 2019 AGM Notice
26th Apr 20196:05 pmRNSShield Therapeutics - PDMR Acquisition of Shares
24th Apr 20197:00 amRNSShield Therapeutics - Major extension to approval in Switzerland
17th Apr 20195:06 pmRNSShield Therapeutics - Grant of share options
17th Apr 20195:01 pmRNSShield Therapeutics - PDMR Acquisition of Shares and Additional Listing
17th Apr 20194:56 pmRNSShield Therapeutics - PDMR Acquisition of Shares
11th Apr 20194:40 pmRNSShield Therapeutics - Holding(s) in Company
8th Apr 20193:42 pmRNSShield Therapeutics - Additional Listing
3rd Apr 20197:00 amRNSShield Therapeutics - Final Results
1st Apr 20195:44 pmRNSShield Therapeutics - Additional Listing
1st Apr 201912:00 pmRNSShield Therapeutics - Change of Adviser
27th Mar 20197:00 amRNSShield Therapeutics - Notice of Results
14th Mar 20193:31 pmRNSShield Therapeutics - Positive decision on Feraccru®'s process patent
4th Mar 20197:00 amRNSShield Therapeutics - Positive results for Feraccru® in AEGIS-H2H study
29th Jan 20197:00 amRNSShield Therapeutics - Positive results of AEGIS-CKD study
24th Jan 20197:00 amRNSShield Therapeutics - Business and trading update
23rd Jan 201910:19 amRNSShield Therapeutics - Investor presentations
22nd Jan 20197:00 amRNSShield Therapeutics - Appointment of Chairman
5th Dec 201810:04 amRNSShield Therapeutics - UK launch of Feraccru® by Norgine
3rd Dec 20187:00 amRNSShield Therapeutics - New Drug Application for Feraccru®
1st Oct 20181:54 pmRNSShield Therapeutics - Notification Of Major Holdings
24th Sep 20181:06 pmRNSShield Therapeutics - Director/PDMR Shareholding
24th Sep 20181:02 pmRNSShield Therapeutics - Holding(s) in Company
19th Sep 20187:14 amRNSShield Therapeutics - Licence for the commercialisation of Feraccru
19th Sep 20187:12 amRNSShield Therapeutics - Interim Results
9th Jul 20184:27 pmRNSShield Therapeutics - Holdings in Company
9th Jul 20184:26 pmRNSShield Therapeutics - Holdings in Company
15th May 20186:21 pmRNSShield Therapeutics - Grant of share options
4th May 20189:20 amRNSShield Therapeutics - Holding(s) in Company
3rd May 20185:26 pmRNSShield Therapeutics - Holding(s) in Company
2nd May 201811:00 amRNSShield Therapeutics - Price Monitoring Extension
16th Mar 20187:00 amRNSShield Therapeutics - Update on the AEGIS-CKD study
12

Login to your account

Don't have an account? Click here to register.